Ofir Livne1, Dvora Shmulewitz1, Aaron L Sarvet1, Melanie M Wall1, Deborah S Hasin1. 1. Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Livne, Hasin); New York State Psychiatric Institute, New York (Shmulewitz, Hasin); Department of Psychiatry, Columbia University Medical Center, New York (Shmulewitz, Wall, Hasin); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Sarvet).
Abstract
OBJECTIVE: The authors sought to determine the association of cannabis indicators with self-reported psychotic disorders in the U.S. general population. METHODS: Participants were from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC; 2001-2002; N=43,093) and NESARC-III (2012-2013; N=36,309). Logistic regression was used to estimate standardized prevalences of past-year self-reported psychotic disorders within each survey and to evaluate the association of past-year self-reported psychotic disorders with indicators of nonmedical cannabis use (any use; frequent use [at least three times/week], daily/near-daily use, and DSM-IV cannabis use disorder) compared with those with no past-year nonmedical cannabis use. Whether the strength of associations differed between surveys was indicated by difference-in-difference tests (between-survey contrasts) and ratios of odds ratios between surveys. RESULTS: Self-reported psychotic disorders were significantly more prevalent among participants with any nonmedical cannabis use than those without (2001-2002: 1.65% compared with 0.27%; 2012-2013: 1.89% compared with 0.68%). In 2001-2002, self-reported psychotic disorders were unrelated to either frequent use or daily/near-daily use. However, in 2012 - 2013, compared with nonusers, self-reported psychotic disorders were more common among participants with frequent use and those with daily/near-daily nonmedical cannabis use (2012-2013: 2.79% and 2.52%, respectively, compared with 0.68% among nonusers). Self-reported psychotic disorders were significantly more prevalent among participants with cannabis use disorder than nonusers in both surveys (2001-2002: 2.55% compared with 0.27%; 2012 - 2013: 3.38% compared with 0.68%). The strength of these associations did not change over time. CONCLUSIONS: Data from the U.S. general population, especially more recent data, suggest associations between self-reported psychotic disorder and frequent nonmedical cannabis use and cannabis use disorder. Clinicians and policy makers should consider these relationships when monitoring patients and formulating programs.
OBJECTIVE: The authors sought to determine the association of cannabis indicators with self-reported psychotic disorders in the U.S. general population. METHODS: Participants were from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC; 2001-2002; N=43,093) and NESARC-III (2012-2013; N=36,309). Logistic regression was used to estimate standardized prevalences of past-year self-reported psychotic disorders within each survey and to evaluate the association of past-year self-reported psychotic disorders with indicators of nonmedical cannabis use (any use; frequent use [at least three times/week], daily/near-daily use, and DSM-IV cannabis use disorder) compared with those with no past-year nonmedical cannabis use. Whether the strength of associations differed between surveys was indicated by difference-in-difference tests (between-survey contrasts) and ratios of odds ratios between surveys. RESULTS: Self-reported psychotic disorders were significantly more prevalent among participants with any nonmedical cannabis use than those without (2001-2002: 1.65% compared with 0.27%; 2012-2013: 1.89% compared with 0.68%). In 2001-2002, self-reported psychotic disorders were unrelated to either frequent use or daily/near-daily use. However, in 2012 - 2013, compared with nonusers, self-reported psychotic disorders were more common among participants with frequent use and those with daily/near-daily nonmedical cannabis use (2012-2013: 2.79% and 2.52%, respectively, compared with 0.68% among nonusers). Self-reported psychotic disorders were significantly more prevalent among participants with cannabis use disorder than nonusers in both surveys (2001-2002: 2.55% compared with 0.27%; 2012 - 2013: 3.38% compared with 0.68%). The strength of these associations did not change over time. CONCLUSIONS: Data from the U.S. general population, especially more recent data, suggest associations between self-reported psychotic disorder and frequent nonmedical cannabis use and cannabis use disorder. Clinicians and policy makers should consider these relationships when monitoring patients and formulating programs.
Entities:
Keywords:
Cannabis; Psychotic Disorders; Substance-Related and Addictive Disorders
Authors: Suman Chandra; Mohamed M Radwan; Chandrani G Majumdar; James C Church; Tom P Freeman; Mahmoud A ElSohly Journal: Eur Arch Psychiatry Clin Neurosci Date: 2019-01-22 Impact factor: 5.270
Authors: Hannah Carliner; Pia M Mauro; Qiana L Brown; Dvora Shmulewitz; Reanne Rahim-Juwel; Aaron L Sarvet; Melanie M Wall; Silvia S Martins; Geoffrey Carliner; Deborah S Hasin Journal: Drug Alcohol Depend Date: 2016-11-11 Impact factor: 4.492
Authors: Marta Di Forti; Arianna Marconi; Elena Carra; Sara Fraietta; Antonella Trotta; Matteo Bonomo; Francesca Bianconi; Poonam Gardner-Sood; Jennifer O'Connor; Manuela Russo; Simona A Stilo; Tiago Reis Marques; Valeria Mondelli; Paola Dazzan; Carmine Pariante; Anthony S David; Fiona Gaughran; Zerrin Atakan; Conrad Iyegbe; John Powell; Craig Morgan; Michael Lynskey; Robin M Murray Journal: Lancet Psychiatry Date: 2015-02-25 Impact factor: 27.083
Authors: J Onwumere; C Bonetto; A Lasalvia; E Miglietta; A Veronese; F Bellini; M Imbesi; P Bebbington; E Kuipers; M Ruggeri Journal: Epidemiol Psychiatr Sci Date: 2019-04-10 Impact factor: 6.892